UGX202 Injection in Patients With Advanced Retinitis Pigmentosa
Clinical trial NCT07311863 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07311863
- Sponsor
- Suzhou UgeneX Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.